Chemistry:Racivir
From HandWiki
Short description: Medication
![]() | |
Clinical data | |
---|---|
Routes of administration | Investigational |
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
NIAID ChemDB | |
Chemical and physical data | |
Formula | C8H10FN3O3S |
Molar mass | 247.24 g·mol−1 |
3D model (JSmol) | |
| |
|
Racivir is an experimental nucleoside reverse transcriptase inhibitor (NRTI), developed by Pharmasset for the treatment of HIV.[1] It is the enantiomer of emtricitabine, a widely used NRTI, meaning that the two compounds are mirror images of each other.
![](/wiki/images/thumb/0/09/Emtricitabine_structure.svg/250px-Emtricitabine_structure.svg.png)
Emtricitabine, the enantiomer of racivir and a widely used NRTI
References
- ↑ "Racivir". AIDSmeds.com. March 24, 2006. http://www.aidsmeds.com/archive/Racivir_1590.shtml.
![]() | Original source: https://en.wikipedia.org/wiki/Racivir.
Read more |